Gabelli Funds’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-123,631
| Closed | -$8.91M | – | 1468 |
|
|
2020
Q4 | $8.91M | Buy |
123,631
+34,536
| +39% | +$1.81M | 0.06% | 349 |
|
|
2020
Q3 | $4.06M | Buy |
89,095
+11,000
| +14% | +$460K | 0.03% | 495 |
|
|
2020
Q2 | $3.53M | Sell |
78,095
-2,000
| -2% | -$89.6K | 0.03% | 521 |
|
|
2020
Q1 | $3.08M | Sell |
80,095
-5,405
| -6% | -$249K | 0.03% | 527 |
|
|
2019
Q4 | $3.96M | Sell |
85,500
-500
| -0.6% | -$21.7K | 0.03% | 568 |
|
|
2019
Q3 | $3.5M | Buy |
86,000
+33,000
| +62% | +$1.42M | 0.02% | 600 |
|
|
2019
Q2 | $2.55M | Buy |
53,000
+26,000
| +96% | +$1.37M | 0.02% | 704 |
|
|
2019
Q1 | $1.69M | Hold |
27,000
| – | – | 0.01% | 796 |
|
|
2018
Q4 | $1.61M | Sell |
27,000
-2,000
| -7% | -$120K | 0.01% | 775 |
|
|
2018
Q3 | $1.87M | Sell |
29,000
-26,000
| -47% | -$1.45M | 0.01% | 807 |
|
|
2018
Q2 | $2.48M | Sell |
55,000
-43,000
| -44% | -$1.71M | 0.01% | 736 |
|
|
2018
Q1 | $3.04M | Hold |
98,000
| – | – | 0.02% | 674 |
|
|
2017
Q4 | $2.93M | Buy |
+98,000
| New | +$2.84M | 0.02% | 693 |
|
|
2016
Q3 | – | Sell |
-76,690
| Closed | -$1.25M | – | 1209 |
|
|
2016
Q2 | $1.25M | Sell |
76,690
-45,310
| -37% | -$667K | 0.01% | 894 |
|
|
2016
Q1 | $1.43M | Buy |
122,000
+20,153
| +20% | +$225K | 0.01% | 835 |
|
|
2015
Q4 | $1.19M | Buy |
+101,847
| New | +$1.29M | 0.01% | 871 |
|
|
2015
Q3 | – | Sell |
-117,800
| Closed | -$1.11M | – | 1145 |
|
|
2015
Q2 | $1.11M | Sell |
117,800
-2,200
| -2% | -$20.4K | 0.01% | 869 |
|
|
2015
Q1 | $1.06M | Buy |
120,000
+30,909
| +35% | +$312K | 0.01% | 865 |
|
|
2014
Q4 | $894K | Buy |
89,091
+4,091
| +5% | +$35.1K | ﹤0.01% | 898 |
|
|
2014
Q3 | $570K | Buy |
85,000
+20,000
| +31% | +$140K | ﹤0.01% | 966 |
|
|
2014
Q2 | $466K | Buy |
+65,000
| New | +$517K | ﹤0.01% | 980 |
|
Other funds holding BEAT
Gabelli Funds's BEAT Position: Q1 2021 in Review
Gabelli Funds sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 123,631 shares — an estimated $8.91M sold.
Gabelli Funds first reported a position in BEAT in Q2 2014 and held it in 21 quarters. The position peaked at $8.91M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Gabelli Funds reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Gabelli Funds sold 123,631 BioTelemetry, Inc. shares in Q1 2021, an estimated $8.91M.
- Gabelli Funds first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 21 quarters.
- Gabelli Funds's BioTelemetry, Inc. position peaked at $8.91M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.